Mitch Scanlan is an experienced sales and marketing professional with a strong background in driving the growth and commercialization of technologies and services in the life sciences sector. He currently serves as the Chief Executive Officer of Biogelx, a University of Strathclyde spin-out specializing in synthetic peptide hydrogels for 3D cell culture and bioprinting applications. In this role, Scanlan is focused on expanding the company's innovative biomaterial technology platform and exploring new commercial partnerships.